Compounds for cancer imaging and therapy

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 295/15 (2006.01) A61K 51/00 (2006.01) A61K 51/04 (2006.01) C07B 59/00 (2006.01) C07C 233/78 (2006.01) C07C 235/60 (2006.01) C07D 207/09 (2006.01) C07D 209/08 (2006.01) C07D 211/26 (2006.01) C07D 295/13 (2006.01) C07D 307/79 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2139503

2139503 9426314 PCTABScor01 The present invention relates to compounds having affinity for certain cancer cells, e.g. lung carcinomas, colon carcinomas, renal carcinomas, malignant melanomas, gliomas, neuroblastomas and pheochromocytomas. The compounds also bind with high specificity to cell surface sigma receptors and can therefore be used for diagnostic imaging of any tissue having an abundance of cells with sigma receptors. The compounds are of general formula (I) wherein X is a radionuclide; R2 is -N(R3)2 or a 5 to 6 member nitrogen containing heterocyclic ring, optionally substituted with at least one alkyl group; the remaining variables are defined on page 5 of the disclosure. Methods are provided for diagnostic imaging and for the detection and treatment of tumors containing the cancer cells described above.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compounds for cancer imaging and therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for cancer imaging and therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for cancer imaging and therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1843443

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.